Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chemotherapy and SBRT in Locally Advanced Pancreatic Cancer
NCT07407231Recruiting
- Sponsor
- Institute of Oncology Ljubljana
- Start
- Sep 2021
- Primary completion
- Sep 2024
- Countries
- 1
01
Overview
Open-label, single-arm trial in pancreatic cancer (PC), sponsored by Institute of Oncology Ljubljana. Primary endpoint: Treatment Response Rate at 12 weeks. Started Sep 2021; status: recruiting.
02
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT07407231.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07407231.